Skip to main content
Livermore
Livermore
ZHEN

Harpoon Therapeutics, Inc.

HARPDelisted Mar 11, 2024
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001708493

Harpoon Therapeutics, Inc. was delisted on Mar 11, 2024; its insiders filed their last Form 4 on Mar 11, 2024; 41 institutions reported holding it in 13F filings for Q4 2023, worth $175.5M in total; no superinvestor held it.

13F holders, Q1 2023

Institutional positions in Harpoon Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
46
−2 vs. Q4 2022
Shares held
17.4M
−1.38M (−7.3%) vs. Q4 2022
Total value
$12.9M
−$700.0K (−5.1%) vs. Q4 2022
New holders
10
11 more added
Sold out
12
9 more reduced

1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting HARP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2023: 46 institutions
Q1 2021: 88 institutionsQ2 2021: 85 institutionsQ3 2021: 93 institutionsQ4 2021: 84 institutionsQ1 2022: 79 institutionsQ2 2022: 63 institutionsQ3 2022: 52 institutionsQ4 2022: 49 institutionsQ1 2023: 46 institutionsQ2 2023: 44 institutionsQ3 2023: 32 institutionsQ4 2023: 41 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ1 2023: $12.9M
Q1 2021: $562.3MQ2 2021: $357.3MQ3 2021: $203.9MQ4 2021: $196.3MQ1 2022: $128.2MQ2 2022: $43.4MQ3 2022: $21.0MQ4 2022: $13.7MQ1 2023: $12.9MQ2 2023: $12.0MQ3 2023: $7.53MQ4 2023: $175.5MQ1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding HARP and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 202341$175.5M
Q3 202332$7.53M
Q2 202344$12.0M
Q1 202346$12.9M
Q4 202249$13.7M
Q3 202252$21.0M
Q2 202263$43.4M
Q1 202279$128.2M
Q4 202184$196.3M
Q3 202193$203.9M
Q2 202185$357.3M
Q1 202188$562.3M

Institutions, Q1 2023

Shares, value and share of portfolio for each institution holding Harpoon Therapeutics, Inc.; share changes are against Q4 2022.

Institutions holding HARP in Q1 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Simplex Trading, LLC885$00.00%−4,512−83.6%Reduced
Royal Bank of Canada600$00.00%+600New
Hantz Financial Services, Inc.22$00.00%+22New
FMR LLC30$220.00%+30New
Investors Research Corp60$450.00%00.0%Unchanged
Beaird Harris Wealth Management, LLC75$560.00%00.0%Unchanged
US Bancorp89$660.00%00.0%Unchanged
BNP Paribas Arbitrage, SA428$3190.00%−1,003−70.1%Reduced
Wells Fargo & Company847$6300.00%+303+55.7%Added
JPMorgan Chase & Co1,436$1.00K0.00%+73+5.4%Added
Federation des caisses Desjardins du Quebec2,000$1.49K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.2,098$1.56K0.00%+567+37.0%Added
UBS Group AG2,542$1.89K0.00%00.0%Unchanged
Federated Hermes, Inc.2,851$2.12K0.00%+180+6.7%Added
Morgan Stanley3,724$2.77K0.00%+784+26.7%Added
Barclays PLC6,762$5.03K0.00%+600+9.7%Added
Tower Research Capital LLC (TRC)10,232$8.00K0.00%−3,656−26.3%Reduced
Bank of America Corp22,449$16.7K0.00%+20,086+850.0%Added
Synovus Financial Corp23,000$17.1K0.00%00.0%Unchanged
Zacks Investment Management30,042$22.4K0.00%+30,042New
CM Wealth Advisors LLC50,354$29.0K0.01%+50,354New
Prudential Financial Inc43,400$32.3K0.00%+43,400New
Northern Trust Corp52,947$39.4K0.00%−45−0.1%Reduced
Susquehanna International Group, LLP53,949$40.1K0.00%+33,830+168.1%Added
Two Sigma Investments, LP57,080$42.5K0.00%+57,080New
Bailard, Inc.63,200$47.0K0.00%+63,200New
State Street Corp85,232$63.4K0.00%00.0%Unchanged
Sequoia Financial Advisors, LLC100,000$74.4K0.00%+40,000+66.7%Added
Bridgeway Capital Management, LLC100,000$74.4K0.00%+50,000+100.0%Added
Acadian Asset Management LLC113,702$84.0K0.00%−13,252−10.4%Reduced
Lion Point Capital, LP169,283$126.0K0.07%+169,283New
Renaissance Technologies LLC196,420$146.0K0.00%−136,554−41.0%Reduced
Geode Capital Management, LLC216,431$161.1K0.00%00.0%Unchanged
Tekla Capital Management LLC259,910$193.4K0.01%00.0%Unchanged
BlackRock Inc.426,786$317.6K0.00%−154,137−26.5%Reduced
Kennedy Capital Management, Inc.529,934$394.4K0.01%+368,444+228.2%Added
Cormorant Asset Management, LP540,600$402.0K0.03%00.0%Unchanged
OrbiMed Advisors LLC621,218$462.3K0.01%−895,278−59.0%Reduced
Millennium Management LLC652,823$486.0K0.00%−583,466−47.2%Reduced
Artal Group S.A.1,000,000$744.0K0.04%00.0%Unchanged
Vanguard Group Inc1,153,148$858.2K0.00%00.0%Unchanged
Franklin Resources Inc1,323,286$984.8K0.00%00.0%Unchanged
MPM Asset Management LLC3,131,388$2.33M0.97%00.0%Unchanged
New Leaf Venture Partners, L.L.C.3,156,699$2.34M1.93%00.0%Unchanged
MPM Oncology Impact Management LP3,196,707$2.38M0.62%00.0%Unchanged
IFP Advisors, Inc29––+29New
Levin Capital Strategies, L.P.0$00.00%−330,000−100.0%Sold out
Goldman Sachs Group Inc0$00.00%−111,601−100.0%Sold out
Two Sigma Securities, LLC0$00.00%−30,702−100.0%Sold out
Citadel Advisors LLC0$00.00%−14,457−100.0%Sold out
Virtu Financial LLC0$00.00%−11,841−100.0%Sold out
Commonwealth Equity Services, LLC0$00.00%−10,000−100.0%Sold out
Belpointe Asset Management LLC0$00.00%−1,900−100.0%Sold out
FNY Investment Advisers, LLC0$00.00%−2,000−100.0%Sold out
The PNC Financial Services Group, Inc.0$00.00%−332−100.0%Sold out
GWM Advisors LLC0$00.00%−115−100.0%Sold out
Citigroup Inc0$00.00%−38−100.0%Sold out
Cutler Group LP0$00.00%−600−100.0%Sold out
Telemetry Investments, L.L.C.––––Not filed